Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Lymphatic Metastasis

NCT03776591 2026-05-14

D3/CME

Phase NA Active not recruiting

128 enrolled

Gastrointestinal

Colonic Neoplasms, Lymphatic Metastasis, Neoplastic Cells, Circulating

NCT07552207 2026-05-04

PKUCH-R12

Phase NA Not yet recruiting

30 enrolled

Gastrointestinal

Lymphatic Metastasis, Rectal Neoplasms

NCT07538193 2026-04-20

Iparomlimab and Tuvonralimab Plus Chemotherapy Before Surgery for Stage III Lung Cancer

Phase NA Not yet recruiting

28 enrolled

Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lymphatic Metastasis

NCT06048146 2026-04-06

A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis

Phase NA Completed

180 enrolled

Gastrointestinal

Gastrointestinal Neoplasms, Intestinal Neoplasms, Lymphatic Metastasis, Rectal Diseases, Rectal Neoplasms

NCT07200466 2026-03-27

ENDORISK-I

Phase NA Recruiting

735 enrolled

Gynecologic

Lymphatic Metastasis, Endometrial Neoplasms

NCT06252129 2026-03-05

Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens

Phase NA Recruiting

160 enrolled

Thoracic

Lung Neoplasms, Lymphatic Metastasis, Pathologic Processes

NCT06264167 2026-02-20

NODE

Phase NA Recruiting

30 enrolled

Gynecologic

Lymphatic Metastasis, Vulvar Neoplasms

NCT07362485 2026-01-23

INIGMA

Phase NA Recruiting

90 enrolled

Breast

Breast Neoplasms, Lymphatic Metastasis

NCT07025785 2026-01-15

Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer

Phase NA Recruiting

100 enrolled

Breast

Breast Neoplasms, Lymphatic Metastasis, Neoplasm, Residual

NCT07146295 2026-01-12

INFINITE

Phase NA Recruiting

1,760 enrolled

Breast

Breast Neoplasms, Lymphatic Metastasis

NCT07328243 2026-01-09

IRE-TCLN

Phase NA Recruiting

85 enrolled

Lymphatic Metastasis

NCT06527027 2025-12-30

LN-RADS, RECIST 1.1 and Node-RADS Classification in the Assessment of Lymph Nodes

Phase NA Recruiting

1,000 enrolled

Lymphadenopathy, Lymphatic Metastasis, Recurrence

NCT06623578 2025-12-03

Comparative Study of Transaxillary Robotic Thyroidectomy With MRND Versus Conventional Open Surgery in N1b PTC

Phase NA Recruiting

876 enrolled

EndocrineHead & Neck

Thyroid Cancer, Papillary, Lymphatic Metastasis

NCT05236686 2025-11-19

Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer

Phase NA Recruiting

94 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Lymphatic Metastasis, Ovarian Neoplasms

NCT03545256 2025-09-30

SACO

Phase NA Recruiting

25 enrolled

Head & Neck

Head and Neck Neoplasms, Lymphatic Metastasis

NCT05735795 2025-08-24

Feasibility of Carbon-Dye Marking of Axillary Lymph Nodes Before Neoadjuvant Chemotherapy in Patients With Breast Cancer

Phase NA Completed

50 enrolled

Breast

Breast Neoplasms, Lymphatic Metastasis

NCT06621823 2025-06-15

R-LYNUS

Phase NA Recruiting

160 enrolled

Lymphatic Metastasis

Clinical Trials

XR-NeckLND

D3/CME

PKUCH-R12

Iparomlimab and Tuvonralimab Plus Chemotherapy Before Surgery for Stage III Lung Cancer

A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis

ENDORISK-I

Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens

NODE

INIGMA

Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer

INFINITE

IRE-TCLN

LN-RADS, RECIST 1.1 and Node-RADS Classification in the Assessment of Lymph Nodes

Comparative Study of Transaxillary Robotic Thyroidectomy With MRND Versus Conventional Open Surgery in N1b PTC

Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer

SACO

Feasibility of Carbon-Dye Marking of Axillary Lymph Nodes Before Neoadjuvant Chemotherapy in Patients With Breast Cancer

R-LYNUS